Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-10

FDA Approved: RAMELTEON — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an Abbreviated New Drug Application for ramelteon from Aurobindo Pharma Limited, marking the generic version's approval. Ramelteon is used to treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)